Literature DB >> 7544188

"Rebound" phenomenon of hepatitis C viremia after interferon therapy in "relapsed" patients with chronic hepatitis C.

H Hanada1, K Hino, K Fujii, M Okazaki, K Okita.   

Abstract

The correlation between serum hepatitis C virus (HCV)-RNA and aminotransferase levels following completion of interferon therapy was evaluated in eight relapsed patients with chronic hepatitis C. Both HCV-RNA and aminotransferase levels were significantly increased in the relapsed patients 1 month after completion of therapy, compared to pretreatment values, despite aminotransferase levels being normal and HCV-RNA being undetectable by reverse transcription polymerase chain reaction assay at the end of therapy. The serum levels of HCV-RNA and aminotransferase were significantly elevated 1 and 2 months post-treatment. They then decreased to pretreatment values 3-5 months after the completion of therapy. Thus, in relapsed patients after the completion of therapy, the changes in HCV-RNA levels preceded the elevation in aminotransferase levels. These findings suggest a correlation between serum HCV-RNA levels and aminotransferase levels in relapsed patients with chronic hepatitis C after the completion of interferon therapy.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7544188     DOI: 10.1007/bf02347510

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  18 in total

1.  Detection of the minus strand of hepatitis C virus RNA by reverse transcription and polymerase chain reaction: implications for hepatitis C virus replication in infected tissue.

Authors:  T Takehara; N Hayashi; E Mita; H Hagiwara; K Ueda; K Katayama; A Kasahara; H Fusamoto; T Kamada
Journal:  Hepatology       Date:  1992-03       Impact factor: 17.425

2.  T-lymphocyte response to hepatitis C virus in different clinical courses of infection.

Authors:  P Botarelli; M R Brunetto; M A Minutello; P Calvo; D Unutmaz; A J Weiner; Q L Choo; J R Shuster; G Kuo; F Bonino
Journal:  Gastroenterology       Date:  1993-02       Impact factor: 22.682

3.  Serial assay of hepatitis C virus RNA in serum for predicting response to interferon-alpha therapy.

Authors:  K Hino; M Okuda; T Konishi; H Ishiko; K Okita
Journal:  Dig Dis Sci       Date:  1995-01       Impact factor: 3.199

4.  Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial.

Authors:  G L Davis; L A Balart; E R Schiff; K Lindsay; H C Bodenheimer; R P Perrillo; W Carey; I M Jacobson; J Payne; J L Dienstag
Journal:  N Engl J Med       Date:  1989-11-30       Impact factor: 91.245

5.  Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial.

Authors:  A M Di Bisceglie; P Martin; C Kassianides; M Lisker-Melman; L Murray; J Waggoner; Z Goodman; S M Banks; J H Hoofnagle
Journal:  N Engl J Med       Date:  1989-11-30       Impact factor: 91.245

6.  Detection, semiquantitation, and genetic variation in hepatitis C virus sequences amplified from the plasma of blood donors with elevated alanine aminotransferase.

Authors:  P P Ulrich; J M Romeo; P K Lane; I Kelly; L J Daniel; G N Vyas
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

7.  Quantification of hepatitis C virus by competitive reverse transcription-polymerase chain reaction: increase of the virus in advanced liver disease.

Authors:  N Kato; O Yokosuka; K Hosoda; Y Ito; M Ohto; M Omata
Journal:  Hepatology       Date:  1993-07       Impact factor: 17.425

8.  Detection of hepatitis C virus RNA in serum of patients with chronic hepatitis C treated with interferon-alpha.

Authors:  H Hagiwara; N Hayashi; E Mita; K Ueda; T Takehara; A Kasahara; H Fusamoto; T Kamada
Journal:  Hepatology       Date:  1992-01       Impact factor: 17.425

9.  Hepatitis C viraemia rebound after "successful" interferon therapy in patients with chronic non-A, non-B hepatitis.

Authors:  J A Garson; S Brillanti; C Ring; P Perini; M Miglioli; L Barbara
Journal:  J Med Virol       Date:  1992-07       Impact factor: 2.327

10.  Establishment of a human T-cell clone cytotoxic for both autologous and allogeneic hepatocytes from chronic hepatitis patients with type non-A, non-B virus.

Authors:  M Imawari; M Nomura; T Kaieda; T Moriyama; K Oshimi; I Nakamura; T Gunji; S Ohnishi; T Ishikawa; H Nakagama
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.